Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1948 1
1951 1
1952 3
1954 1
1957 1
1958 2
1960 1
1961 1
1962 4
1963 4
1964 7
1965 8
1966 10
1967 22
1968 67
1969 63
1970 85
1971 93
1972 93
1973 130
1974 162
1975 179
1976 197
1977 248
1978 275
1979 423
1980 412
1981 378
1982 419
1983 511
1984 721
1985 800
1986 687
1987 730
1988 902
1989 1029
1990 1055
1991 1213
1992 1332
1993 1488
1994 1606
1995 1540
1996 1574
1997 1678
1998 1638
1999 1582
2000 1446
2001 1439
2002 1724
2003 1848
2004 1907
2005 2150
2006 2287
2007 2493
2008 2630
2009 2939
2010 3241
2011 3483
2012 3709
2013 4040
2014 4505
2015 5121
2016 5469
2017 6641
2018 6620
2019 7639
2020 14940
2021 18554
2022 25267
2023 30813
2024 12471

Text availability

Article attribute

Article type

Publication date

Search Results

174,405 results

Results by year

Filters applied: . Clear all
Page 1
What Is PDGM?
Pierotti D. Pierotti D. Home Healthc Now. 2019 Mar/Apr;37(2):126-127. doi: 10.1097/NHH.0000000000000768. Home Healthc Now. 2019. PMID: 30829796 No abstract available.
Resource management.
Lack JA. Lack JA. Anaesthesia. 1992 Jul;47(7):549-50. doi: 10.1111/j.1365-2044.1992.tb02319.x. Anaesthesia. 1992. PMID: 1626662 Free article. No abstract available.
Resource utilization.
Moore FD. Moore FD. Ann Surg. 1985 Jul;202(1):126-7. doi: 10.1097/00000658-198507000-00020. Ann Surg. 1985. PMID: 3925902 Free PMC article. No abstract available.
Economic evaluation.
Drummond MF, Aguiar-Ibanez R, Nixon J. Drummond MF, et al. Singapore Med J. 2006 Jun;47(6):456-61; quiz 462. Singapore Med J. 2006. PMID: 16752012 Free article.
The financial burden of cancer care: do patients in the US know what to expect?
Peppercorn J. Peppercorn J. Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):835-42. doi: 10.1586/14737167.2014.963558. Epub 2014 Oct 1. Expert Rev Pharmacoecon Outcomes Res. 2014. PMID: 25269513 Review.
Patients in the USA face potentially high financial burdens from the costs of cancer care, distinct from the challenges of societal costs and the economic impact of the disease itself. ...This paper reviews the challenge of appropriately educating patients regarding fin …
Patients in the USA face potentially high financial burdens from the costs of cancer care, distinct from the challenges of societal c …
ECONOMIC ISSUES IN THERAPEUTIC DRUG MONITORING.
Petryszyn P, Wiela-Hojeńska A. Petryszyn P, et al. Acta Pol Pharm. 2016 May-Jun;73(3):599-604. Acta Pol Pharm. 2016. PMID: 27476276 Review.
The fact that resources for health care are limited has been found as a rationale for the development of pharmacoeconomics. Pharmacoeconomic analysis identifies, measures and compares the costs and the economic, clinical and humanistic outcomes of diseases, drug the …
The fact that resources for health care are limited has been found as a rationale for the development of pharmacoeconomics. Ph …
The global burden of sepsis: barriers and potential solutions.
Rudd KE, Kissoon N, Limmathurotsakul D, Bory S, Mutahunga B, Seymour CW, Angus DC, West TE. Rudd KE, et al. Crit Care. 2018 Sep 23;22(1):232. doi: 10.1186/s13054-018-2157-z. Crit Care. 2018. PMID: 30243300 Free PMC article. Review.
Barriers to reducing the global burden of sepsis include difficulty quantifying attributable morbidity and mortality, low awareness, poverty and health inequity, and under-resourced and low-resilience public health and acute health care delivery system …
Barriers to reducing the global burden of sepsis include difficulty quantifying attributable morbidity and mortality, low awareness, poverty …
Cost of rheumatic disorders in the Netherlands.
van den Akker-van Marle ME, Chorus AM, Vliet Vlieland TP, van den Hout WB. van den Akker-van Marle ME, et al. Best Pract Res Clin Rheumatol. 2012 Oct;26(5):721-31. doi: 10.1016/j.berh.2012.08.005. Best Pract Res Clin Rheumatol. 2012. PMID: 23218434 Review.
Data from the National Monitor on Musculoskeletal System 2010 were used to assess resource used, multiplied with standard prices for the Netherlands to obtain total costs for the 1.8 million people suffering from rheumatic disorders. ...
Data from the National Monitor on Musculoskeletal System 2010 were used to assess resource used, multiplied with standard prices for …
[Hospital costs estimation by micro and gross-costing approaches].
Guerre P, Hayes N, Bertaux AC; French Costing Group. Guerre P, et al. Rev Epidemiol Sante Publique. 2018 Mar;66 Suppl 2:S65-S72. doi: 10.1016/j.respe.2018.02.001. Epub 2018 Mar 7. Rev Epidemiol Sante Publique. 2018. PMID: 29525184 Review. French.
Should the cost figures reflect the healthcare facility's point of view or enlighten perspectives for the public health insurance system? Another consideration is in regard to the method to adopt, as there are several. ...The aims of this work are: (1) to describe each of …
Should the cost figures reflect the healthcare facility's point of view or enlighten perspectives for the public health insurance sys …
Adherence and resource use among psoriasis patients treated with biologics.
Aleshaki JS, Cardwell LA, Muse ME, Feldman SR. Aleshaki JS, et al. Expert Rev Pharmacoecon Outcomes Res. 2018 Dec;18(6):609-617. doi: 10.1080/14737167.2018.1512408. Epub 2018 Sep 10. Expert Rev Pharmacoecon Outcomes Res. 2018. PMID: 30142007 Review.
INTRODUCTION: The emergence of immune-modulating drugs such as biologics has altered the treatment landscape for psoriasis. However, their use presents high financial costs to patients and healthcare systems. Patient demographic and socioeconomic status may influence adher …
INTRODUCTION: The emergence of immune-modulating drugs such as biologics has altered the treatment landscape for psoriasis. However, their u …
174,405 results
You have reached the last available page of results. Please see the User Guide for more information.